Skip to content

Clinical trials

Terminated Respiratory Tract Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Status: Terminated Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20092
20101
20121
20131
20141
20151
20171
20182
20191
20202
20212
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation3
Aeris Therapeutics1
AstraZeneca1
Bracane Company1
Celgene1
Celularity Incorporated1
Daiichi Sankyo1
Furiex Pharmaceuticals, Inc1
Hoffmann-La Roche1
Janssen Vaccines & Prevention B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases21
Lung Diseases14
Bronchial Neoplasms5
Neoplasms5
Neoplasms by Site5
Respiratory Tract Neoplasms5
Thoracic Neoplasms5
Carcinoma4
Carcinoma, Bronchogenic4
Carcinoma, Non-Small-Cell Lung4

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.